Academic Journal

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
المؤلفون: R. Caporali, M. Filippini, R. Gorla, E.G. Favalli, A. Marchesoni, M. Antivalle, P. Sarzi- Puttini, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni
المصدر: Reumatismo, Vol 60, Iss 4, Pp 290-295 (2011)
بيانات النشر: PAGEPress Publications, 2011.
سنة النشر: 2011
المجموعة: LCC:Medicine
LCC:Internal medicine
مصطلحات موضوعية: Medicine, Internal medicine, RC31-1245
الوصف: Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval of the third anti-TNFα agent (adalimumab) for treating RA patients, the Italian Society of Rheumatology (Società Italiana di Reumatologia [SIR]) started a database for the registration and active follow-up of RA patients treated with biological response modifiers, which contains all of the demographic and clinical parameters, as well as the therapeutic data, usually needed to follow RA patients...
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Italian
تدمد: 0048-7449
2240-2683
Relation: http://www.reumatismo.org/index.php/reuma/article/view/403; https://doaj.org/toc/0048-7449; https://doaj.org/toc/2240-2683
DOI: 10.4081/reumatismo.2008.290
URL الوصول: https://doaj.org/article/a3e6e4291560442c8293fdb98392bc26
رقم الانضمام: edsdoj.3e6e4291560442c8293fdb98392bc26
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00487449
22402683
DOI:10.4081/reumatismo.2008.290